Single-Cell RNA-Seq Datasets of residual AML cells purifed from Patient Derived Xenograft bone marrow treated or not with venetoclax plus cytarabine [Patient TUH07]
Ontology highlight
ABSTRACT: The goal of this study is to compare single cell transcriptome of in vivo AML cells profiling before treatment and after venetoclax and cytarabine in single agent or after the duplet. This study uncovered transcriptionally different cell subpopulations that specifically emerge in VEN+AraC residual disease.
ORGANISM(S): Homo sapiens
PROVIDER: GSE178910 | GEO | 2021/06/26
REPOSITORIES: GEO
ACCESS DATA